HRP20110127T1 - Aksomadol za liječenje kod artritisa - Google Patents

Aksomadol za liječenje kod artritisa Download PDF

Info

Publication number
HRP20110127T1
HRP20110127T1 HR20110127T HRP20110127T HRP20110127T1 HR P20110127 T1 HRP20110127 T1 HR P20110127T1 HR 20110127 T HR20110127 T HR 20110127T HR P20110127 T HRP20110127 T HR P20110127T HR P20110127 T1 HRP20110127 T1 HR P20110127T1
Authority
HR
Croatia
Prior art keywords
pain
use according
drug
axomadol
arthrosis
Prior art date
Application number
HR20110127T
Other languages
English (en)
Croatian (hr)
Inventor
Schiene Klaus
Bloms-Funke Petra
Bothmer John
Lefeber Claudia
Original Assignee
Grnenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grnenthal Gmbh filed Critical Grnenthal Gmbh
Publication of HRP20110127T1 publication Critical patent/HRP20110127T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HR20110127T 2007-05-11 2011-02-23 Aksomadol za liječenje kod artritisa HRP20110127T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007022790A DE102007022790A1 (de) 2007-05-11 2007-05-11 Axomadol zur Schmerzbehandlung bei Arthrose
PCT/EP2008/003755 WO2008138558A1 (fr) 2007-05-11 2008-05-09 Axomadol pour le traitement de la douleur en cas d'arthrose

Publications (1)

Publication Number Publication Date
HRP20110127T1 true HRP20110127T1 (hr) 2011-03-31

Family

ID=39672675

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110127T HRP20110127T1 (hr) 2007-05-11 2011-02-23 Aksomadol za liječenje kod artritisa

Country Status (22)

Country Link
US (2) US20080306161A1 (fr)
EP (1) EP2155179B1 (fr)
JP (1) JP2010526786A (fr)
KR (1) KR20100017781A (fr)
CN (1) CN101742993A (fr)
AT (1) ATE489947T1 (fr)
AU (1) AU2008250621A1 (fr)
CA (1) CA2685379A1 (fr)
CY (1) CY1111328T1 (fr)
DE (2) DE102007022790A1 (fr)
DK (1) DK2155179T3 (fr)
ES (1) ES2357355T3 (fr)
HK (1) HK1141436A1 (fr)
HR (1) HRP20110127T1 (fr)
IL (1) IL202001A0 (fr)
MX (1) MX2009012096A (fr)
PL (1) PL2155179T3 (fr)
PT (1) PT2155179E (fr)
RU (1) RU2009145804A (fr)
SI (1) SI2155179T1 (fr)
WO (1) WO2008138558A1 (fr)
ZA (1) ZA200907646B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011008298A2 (fr) * 2009-07-16 2011-01-20 Nectid, Inc. Nouvelles formes pharmaceutiques de l’axomadol
AR077987A1 (es) 2009-08-28 2011-10-05 Gruenenthal Gmbh Combinacion farmaceutica que comprende 6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol o 6-dimetilaminometil-1-(3-hidroxifenil)-ciclohexano-1,3-diol y un antiepileptico
WO2011029614A1 (fr) 2009-09-14 2011-03-17 Grünenthal GmbH Modifications cristallines de 6-diméthylaminométhyl-1-(3-méthoxy-phényl)-cyclohexane-1,3-diol
WO2012000667A1 (fr) * 2010-06-30 2012-01-05 Grünenthal GmbH Axomadol ou métabolite de celui-ci pour utilisation dans le traitement du syndrome du côlon irritable

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE10004926A1 (de) 2000-02-04 2001-08-09 Gruenenthal Gmbh Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten
DE10059413A1 (de) 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10109763A1 (de) 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
US20050176790A1 (en) * 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
PT1562567T (pt) * 2002-11-22 2017-08-24 Gruenenthal Gmbh Combinação de analgésicos selecionados e inibidores da cox-ii
DE10333835A1 (de) * 2003-07-24 2005-03-10 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung
FI1765303T4 (fi) * 2004-07-01 2023-01-31 Väärinkäytöltä suojattu oraalinen tabletti
US8309610B2 (en) * 2005-02-25 2012-11-13 Gruenenthal Gmbh Crystalline forms of (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexane-1,3-diol hydrochloride
DE102005009217A1 (de) * 2005-02-25 2006-08-31 Grünenthal GmbH Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen

Also Published As

Publication number Publication date
CA2685379A1 (fr) 2008-11-20
IL202001A0 (en) 2010-06-16
SI2155179T1 (sl) 2011-03-31
CY1111328T1 (el) 2015-08-05
US20080306161A1 (en) 2008-12-11
ATE489947T1 (de) 2010-12-15
CN101742993A (zh) 2010-06-16
KR20100017781A (ko) 2010-02-16
DE102007022790A1 (de) 2008-11-20
WO2008138558A1 (fr) 2008-11-20
US20100331424A1 (en) 2010-12-30
MX2009012096A (es) 2009-11-23
EP2155179A1 (fr) 2010-02-24
EP2155179B1 (fr) 2010-12-01
JP2010526786A (ja) 2010-08-05
DE502008001951D1 (de) 2011-01-13
PL2155179T3 (pl) 2011-05-31
DK2155179T3 (da) 2011-03-07
AU2008250621A1 (en) 2008-11-20
HK1141436A1 (en) 2010-11-12
RU2009145804A (ru) 2011-06-20
ES2357355T3 (es) 2011-04-25
PT2155179E (pt) 2011-03-07
ZA200907646B (en) 2010-07-28

Similar Documents

Publication Publication Date Title
HRP20141234T1 (hr) Tapentadol za tretiranje boli od artritisa
HRP20200600T1 (hr) Tapentadol za sprječavanje i liječenje depresije i tjeskobe
BRPI0518266B8 (pt) medicamento oral de liberação modificada de pelo menos um princípio ativo sob a forma multimicrocapsular
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
JP2015515475A5 (fr)
JP2013231087A5 (fr)
HRP20100210T1 (hr) Upotreba alopurinola u liječenju eritrodisestezije dlana i stopala
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
RS52867B (en) GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS
HRP20110127T1 (hr) Aksomadol za liječenje kod artritisa
HRP20161295T1 (hr) Primjena antitumorskog sredstva
HRP20240166T1 (hr) Postupak liječenja prader-willijevog sindroma
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
NZ700924A (en) Dosage regimen for a pi-3 kinase inhibitor
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
AR072951A1 (es) Uso de dronedarona o una sal aceptable farmaceuticamente de esta, para la preparacion de un medicamento para regular el nivel de potasio en la sangre
DE602007012904D1 (de) Neue 2',3'-methylidenacetyladenosine prodrugs zur
JP2019529559A5 (fr)
MY168531A (en) Medicament form for release of active ingredients
ECSP16005208A (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
SG10201803996WA (en) Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
HRP20230735T1 (hr) Betahistin, ili njegova farmaceutski prihvatljiva sol, i inhibitor monoamin oksidaze, za uporabu u liječenju ili prevenciji jednog ili više simptoma vrtoglavice kod subjekta
BR112015022103A2 (pt) composição farmacêutica, método para preparar uma composição farmacêutica, uso de uma composição farmacêutica, e, método para prevenir ou tratar uma doença
BRPI0509305A (pt) uso de um sensibilizador insulìnico, composição farmecêutica, e , kit
HRP20161166T1 (hr) Tapentadol za uporabu u liječenju sindroma iritabilnog crijeva